Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
07/01/2026 10:32
Jan 7 (Reuters) - Medicamen Biotech Ltd MEBI.NS: GETS EU APPROVAL FOR REGISTRATION OF “PARACETAMOL” FROM DENMARK WITH XGX PHARMA Source text: ID:nnAZN4RS1ED Further company coverage: MEBI.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicamen Biotech
See all newsBrief: Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026
Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
India's Medicamen Biotech gains on US FDA nod for blood cancer drug
Brief: Medicamen Biotech Approves Allotment Of Shares, Warrants
India's Medicamen Biotech rises after deal with Denmark's XGX Pharma